FDA offers suite of new guidance on AI, accelerated approvals, clinical trials and more
With two weeks until President-elect Donald Trump’s administration takes over, the FDA on Monday released dozens of new draft and final guidance documents covering everything …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.